Search

Xiangao Huang

from Rego Park, NY
Age ~58
Get Report
Also known as:
Xiango Huang, Huang Xiangao
Related to:
Hao Zhou, 56Hao C HuangShun F Huang, 45Shou A Li, 61Ping H Qiao, 58Kanecka Mc, 47
Connected to:
Abigail Huang, 39Alexandre Huang, 35Alexander L Huang, 66Alisa Huang, 64Allycia L Huang, 49Angelia Huang, 49Annabelle W Huang, 56Arnold Huang, 34Belle Huang, 53Bifang Huang, 55

Xiangao Huang Phones & Addresses

  • Rego Park, NY
  • New York, NY
  • Queens, NY

Resumes

Resumes

Xiangao Huang Photo 1

Assistant Professor Of Research

View page
Location:
6615 Wetherole St, Rego Park, NY 11374
Industry:
Higher Education
Work:
Weill Cornell Medical College
Assistant Professor of Research
Education:
The University of Hong Kong
Doctorates, Doctor of Philosophy, Physiology, Philosophy
Skills:
Molecular Biology
Cell Culture
Biochemistry
Cell Biology
Western Blotting
Lifesciences
Cell
Microscopy
Drug Discovery
Pcr
Neuroscience
Protein Chemistry
Bioinformatics
Protein Expression
In Vivo
Science
Animal Models
Cancer
In Vitro
Protein Purification
Immunology
Genetics
Immunohistochemistry
Assay Development
Qpcr
Languages:
Mandarin
Xiangao Huang Photo 2

Xiangao Huang

View page

Publications

Us Patents

Combination Therapy With Lenalidomide And A Cdk Inhibitor For Treating Multiple Myeloma

View page
US Patent:
20140031325, Jan 30, 2014
Filed:
Dec 5, 2011
Appl. No.:
13/992121
Inventors:
Blake Bartlett - Warren NJ, US
Maurizio Di Liberto - Rivervale NJ, US
Xiangao Huang - Rego Park NY, US
Selina Chen-Kiang - New York NY, US
Assignee:
Celgene Corporation - Summit NJ
International Classification:
A61K 31/573
A61K 31/4439
US Classification:
514171
Abstract:
Provided herein are methods for the treatment of multiple myeloma, wherein the methods comprise administration of lenalidomide and administration of a second active agent such as a CDK inhibitor.

Targeting Cdk4 And Cdk6 In Cancer Therapy

View page
US Patent:
20110009353, Jan 13, 2011
Filed:
Oct 1, 2008
Appl. No.:
12/741884
Inventors:
Selina Chen-Kiang - New York NY, US
Maurizio Di Liberto - Riverdale NJ, US
Xiangao Huang - New York NY, US
International Classification:
A61K 31/496
A61K 31/519
A61K 31/337
A61K 31/454
A61K 31/505
A61K 31/437
A61K 31/4965
A61K 31/41
A61K 31/5377
A61K 31/4353
A61K 31/40
A61K 31/7034
A61K 31/7068
C07H 21/02
A61K 31/7105
C12N 5/09
C12Q 1/18
C12Q 1/68
A61P 35/04
US Classification:
514 34, 51425216, 5142593, 514422, 514326, 514275, 514283, 51425506, 514354, 5142315, 514300, 514381, 514 49, 514449, 514 44 R, 435347, 435 32, 435 6, 536 245
Abstract:
The invention involves methods of inhibiting the cancer cell cycle to make cancer cells more susceptible to chemotherapeutic agents. In particular, inhibition of CDK4 and/or CDK6 inhibits cell cycle progression in cancer cells. When combined with chemotherapy such cell cycle inhibition can effectively treat even aggressive cancer types that are drug-resistant and intractable to most chemotherapies.
Control profile
Xiangao Huang from Rego Park, NY, age ~58 Get Report